- OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal03-28-2019
- OpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock03-26-2019
- OpGen and Merck’s ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial Stewardship03-25-2019
- OpGen Reports Fourth Quarter and 2018 Financial Results and Provides Business Update02-26-2019
Rapid Antibiotic Resistance Surveillance
CONNECT WITH OpGen
We want to add you to our list and stay connected.
Please sign up for email alerts to receive the latest OpGen news.
Microbial Whole Genome Sequencing
Now Available On Demand
Esther Babady, Ph.D
Director of Clinical Microbiology Operations, Memorial Sloan Kettering Cancer Center
This webinar will review current options for rapid pathogen identification from positive blood cultures and discuss the speaker’s experience with the use of AdvanDx QuickFISH® BC kits and their impact on the laboratory workflow and patient outcomes.
Rapid Pathogen Identification